BLUEVAC-RANGE

BLUEVAC, our vaccines against the
different serotypes of bluetongue
virus

A tool for prevention

BLUEVAC is an essential tool in the control of Bluetongue virus (serotype 1, 4 and 8) in sheep and cattle, producing an active immunisation and decreasing the spread of the disease.

Advanced technology of adjuvants

BLUEVAC is based on the use of Aluminum hydroxide and Quil A as adjuvants. Quil A is a derivative of a purified saponin that repositions viral antigens and retards them to be captured by immunity cells from vaccinated animals.

Proven efficacy

Testing and validated by RT-PCR method, BLUEVAC prevents the viraemia, indicating no presence of viral genome after vaccination and making safe.

Less local reactions

The use of the purified Saponin Quil A as an adjuvant, produces no serious local reactions.

Yield benefits

Control of the appearance of clinical cases of Bluetongue disease

Cost-benefit of one dose vs losses associated with clinical signs and decreased production

Control of dissemination of disease and declining trade restrictions

Widely tested

More than 230 million doses of BLUEVAC administered in Europe, have shown to be a valuable method and the best choice to reduce clinical signs and viraemia in sheep and cattle herds.

Decreases the prevalence of Bluetongue

Vaccination with BLUEVAC prevents viraemia and transmission to healthy animals, decreasing the prevalence of the disease in endemic areas.

Packaging benefits

With a collapsible plastic bottle, BLUEVAC has a stronger and lighter packaging, and does not require vented draw-of equipment.

Vaccines against bluetongue :

BLUEVAC RANGE

BLUEVAC RANGE

BLUEVAC-1

Active immunization of cattle and
sheep against bluetongue virus
serotype 1

BLUEVAC-1

BLUEVAC-4

Active immunization of cattle and
sheep against bluetongue virus
serotype 4

BLUEVAC-4

BLUEVAC BTV8

Active immunization of cattle and
sheep against bluetongue virus
serotype 8

BLUEVAC BTV8